Atlas Trials

Biolinq Safety and Effectiveness Trial

Clinical trial NCT06229743 · COMPLETED

Trial details

NCT number
NCT06229743
Sponsor
Biolinq Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus
Start date
2024-02-29
Primary completion
2024-06-10
Enrollment
247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.